News Release

Basel, 12 December 2016 – Lonza Group Ltd notes the recent press speculations that it is in final negotiations with KKR regarding the potential acquisition of Capsugel. Lonza confirms that it has expressed a strong interest in this successful company as it would fit perfectly with Lonza's Healthcare Continuum strategy and strengthen its position as leading supplier to a number of important healthcare markets. A successful acquisition would be value adding and be within Lonza's stated acquisition criteria.

Lonza emphasizes that there can be no certainty as to the outcome of the discussions or whether an acquisition will be completed. More detailed information will follow in case of any significant developments.